Gene · 5893
Papers2,797
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,797
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deficiency in mammalian STN1 promotes colon cancer development via inhibiting DNA repair. | Sci Adv | 2023 | 37163605 | PubTator, text mining | PubMed |
| Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer. | NPJ Breast Cancer | 2023 | 37156759 | PubTator, text mining | PubMed |
| Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer. | Front Immunol | 2023 | 37153619 | PubTator, text mining | PubMed |
| Ubx5-Cdc48 assists the protease Wss1 at DNA-protein crosslink sites in yeast. | EMBO J | 2023 | 37144685 | PubTator, text mining | PubMed |
| Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer. | Front Oncol | 2023 | 37143950 | PubTator, text mining | PubMed |
| Therapeutic disruption of RAD52-ssDNA complexation via novel drug-like inhibitors. | NAR Cancer | 2023 | 37139244 | PubTator, text mining | PubMed |
| Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy. | J Med Chem | 2023 | 37134182 | PubTator, text mining | PubMed |
| Structure-forming CAG/CTG repeats interfere with gap repair to cause repeat expansions and chromosome breaks. | Nat Commun | 2023 | 37120647 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer-associated fibroblast heterogeneity. | Biochim Biophys Acta Rev Cancer | 2023 | 37120098 | PubTator, text mining | PubMed |
| Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation. | Int J Mol Sci | 2023 | 37108815 | PubTator, text mining | PubMed |
| R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance. | Int J Mol Sci | 2023 | 37108225 | PubTator, text mining | PubMed |
| Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease. | Genes (Basel) | 2023 | 37107673 | PubTator, text mining | PubMed |
| Pathway choice in the alternative telomere lengthening in neoplasia is dictated by replication fork processing mediated by EXD2's nuclease activity. | Nat Commun | 2023 | 37105990 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| RAD52 could predict overall survival for patients with renal clear cell carcinoma. | Asian J Surg | 2023 | 37087350 | PubTator, text mining | PubMed |
| Next-generation sequencing study on poorly differentiated carcinoma derived from a thirty-year-old epidermoid cyst: A case report. | Front Oncol | 2023 | 37077824 | PubTator, text mining | PubMed |
| A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells. | Nucleic Acids Res | 2023 | 37070192 | PubTator, text mining | PubMed |
| Saccharomyces cerevisiae DNA polymerase IV overcomes Rad51 inhibition of DNA polymerase δ in Rad52-mediated direct-repeat recombination. | Nucleic Acids Res | 2023 | 37070185 | PubTator, text mining | PubMed |
| The Proteins of mRNA Modification: Writers, Readers, and Erasers. | Annu Rev Biochem | 2023 | 37068770 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5893/papers?page=13